CIBC Bancorp USA’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
CIBC Bancorp USA's PRAX Position: Q3 2026 in Review
CIBC Bancorp USA increased its Praxis Precision Medicines (PRAX) stake by 78% in Q3 2026, buying an estimated $363K and bringing the position to 2,493 shares worth $726K. The position accounts for ﹤0.01% of the portfolio, ranked #1197.
CIBC Bancorp USA first reported a position in PRAX in Q1 2026 and has held it in 3 quarters since. 338 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- CIBC Bancorp USA held 2,493 shares of Praxis Precision Medicines worth $726K as of Q3 2026.
- CIBC Bancorp USA bought 1,096 Praxis Precision Medicines shares in Q3 2026, an estimated $363K.
- Praxis Precision Medicines made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1197 holding.
- CIBC Bancorp USA first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 3 quarters since.
- 338 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.